Anthem Biosciences has selected JM Financial as the lead banker for its IPO, along with Citi and JP Morgan. The company plans to raise Rs 3,300 crore. Anthem's financials showed a turnover of Rs 1,057 crore and a net profit of Rs 385 crore for the fiscal year ending March 2023.